The Biden-Harris administration has proposed a rule to expand Medicare and Medicaid coverage for GLP-1s like Ozempic and Wegovy for weight loss treatment, a move supported by several healthcare leaders. Currently, Medicare is not allowed to cover these drugs for weight loss while only 13 state Medicaid programs do. If approved, the rule could benefit 3.4 million Medicare enrollees and 4 million adult Medicaid enrollees by reducing out-of-pocket costs and increasing access to the medications.
Rapid7 Labs Identifies Malware Installer Targeting Chinese and Vietnamese Users
Rapid7 Labs has discovered a highly evasive malware installer called CleverSoar, which targets Chinese and Vietnamese-speaking users by deploying and protecting several malicious elements including
